Publications by authors named "Merce Ardevol"

Claim this Profile
P
Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practice.
Elena González-Colominas, María-Carlota Londoño, Rosa M Morillas, Xavier Torras, Sergi Mojal

J Gastroenterol Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of ribavirin in interferon-free therapy for the treatment of hepatitisC virus.
Rosa Maria Morillas, Helena Masnou, Mercé Ardévol, Dulce López

Gastroenterol Hepatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients.
Verónica Saludes, Elisabet Bascuñana, Elena Jordana-Lluch, Sònia Casanovas, Mercè Ardèvol

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
Crisanto Diez-Quevedo, Helena Masnou, Ramon Planas, Pere Castellví, Dolors Giménez

J Clin Psychiatry· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors.
Verónica Saludes, Maria Alma Bracho, Oliver Valero, Mercè Ardèvol, Ramón Planas

PLoS One· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis